Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS DIN 02467119

Status: Dormant
Holder: APOTEX INC
Molecule: DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Health Canada record

Active ingredient(s)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MG
Dosage formTablet (Extended-Release)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN06AX23 DESVENLAFAXINE
Original market date26-Apr-2022
Current status date19-Apr-2025
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

DINProductCompanyFormStrengthStatus
02525623AG-DESVENLAFAXINEANGITA PHARMA INC.Tablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02525615AG-DESVENLAFAXINEANGITA PHARMA INC.Tablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02469855INTELLI-DESVENLAFAXINEINTELLIPHARMACEUTICS CORPTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGApproved
02469847INTELLI-DESVENLAFAXINEINTELLIPHARMACEUTICS CORPTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGApproved
02495147JAMP DESVENLAFAXINEJAMP PHARMA CORPORATIONTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02495139JAMP DESVENLAFAXINEJAMP PHARMA CORPORATIONTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02321092PRISTIQPFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02321106PRISTIQPFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02532158SPC-DESVENLAFAXINESUN PHARMA CANADA INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02532166SPC-DESVENLAFAXINESUN PHARMA CANADA INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02458225TEVA-DESVENLAFAXINETEVA CANADA LIMITEDTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02458217TEVA-DESVENLAFAXINETEVA CANADA LIMITEDTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02467127APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETSAPOTEX INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGDormant
02441667GD-DESVENLAFAXINEGENMED A DIVISION OF PFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGCancelled Pre Market
02441675GD-DESVENLAFAXINEGENMED A DIVISION OF PFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGCancelled Pre Market
02526921PRO-DESVENLAFAXINEPRO DOC LIMITEETablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGCancelled Post Market
02526913PRO-DESVENLAFAXINEPRO DOC LIMITEETablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
293772022-11-02Supplement to an Abbreviated New Drug Submission (SANDS)Administrative: Product Name Change. Update to the Product Monograph, Labelling and Package Insert
275792022-02-14Abbreviated New Drug Submission (ANDS)
Request a quote for APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

How to read a Canadian DIN record